Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 EP606 | DOI: 10.1530/endoabs.37.EP606

ECE2015 Eposter Presentations Obesity and cardiovascular endocrinology (108 abstracts)

From genome to gene: genes and genetic variations to be associated with metabolic syndrome

Maryam Daneshpour 1 , Bahareh Sedaghati Khayat 1 , Mehdi Hedayati 1 & Fereidoun Azizi 2


1Research Institute for Endocrine Sciences, Cellular and Molecular Endocrine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Research Institute for Endocrine Sciences, Endocrine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


Introduction: The prevalence of non-communicable disorders such as metabolic syndrome (MetS) is high in developing countries. MetS is a disorder of energy utilisation and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions: abdominal (central) obesity, elevated blood pressure, elevated fasting plasma glucose, high serum triglycerides, and low HDL cholesterol levels. The present review aims to discover the genetic variant reported in association with MetS.

Method and materials: The database for genotypes and phenotypes (dbGaP) and the database for genetic associations and human genome (HuGE navigator) were utilised in order to search for genes and their corresponding polymorphisms related to MetS. Additionally, an electronic literature search for other Iranian studies and the genetic aspect of TLGS was completed using PubMed.

Results: For phenotype selection in PheGenI, 30 traits were chosen and after the analysis, 21 of them were in common results with MetS. After finding the common variation between traits and MetS, omitting the repeated SNPs, 173 variations were remained. Finally, results distinguished six of the most important genetic regions found to have strong association with MetS.

Conclusion: Identifying major genes that are responsible for the MetS may improve the medical care for treating individuals with MetS, and eventually may lead to personalised medicine in which treatment is tailored genetically to the patient’s needs. The present candidate regions is a respectable start to replicate genetic studies in large affected Iranian individual which we hope leads us to improve our medical care in this field.

Article tools

My recent searches

No recent searches.